SELENBP1 and neoplasm: After careful literature research, we found that SELENBP1 that owned lower expression in the low AIDPS group with poor prognosis was associated with better tumor prognosis, and its decreased expression led to poor prognosis of many tumors such as lung adenocarcinoma (Chen et al., 2004).